stockrow
Friday 6 November 2026
Export BLX’s income statement to Excel — free account
Bladex Inc.
Bladex Inc.’s revenue for fiscal 2025 (year ended December 2025) was $836.9 million, up 0.89% from fiscal 2024.
- Revenue
- +12.1%
- EPS
- +13.5%
- Free cash flow
- −117.1%
- Total debt
- +75.8%
Quarter to September 2026, against a year earlier
50.18
0.36
+0.72%
Follow BLX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 3 | 5 | 6 |
+8 more TTM periods Free account |
| 14.08% | 14.74% | 15.04% | 15.05% | ||
| 1.67% | 1.72% | 1.77% | 1.84% | ||
ROIC |
2.59% | 3.69% | 3.82% | 3.75% | |
Return on Tangible Assets |
4.05% | 5.61% | 5.61% | 5.26% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (6.07) | 21.27 | 20.93 | |
Free Cash Flow |
— | (228.08) | 795.30 | 777.45 | |
Capital Expenditures |
— | (1.75) | (2.62) | (2.80) | |
| Other line items | |||||
Cash ROIC |
0.00% | (2.93%) | 10.18% | 10.19% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.07 | 0.07 | 0.07 | 0.08 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
5,848.07 | 5,933.36 | 5,486.10 | 4,873.91 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.64% | 13.15% | 12.99% | 12.89% | |
Share Based Compensation of Revenue |
0.00% | 1.07% | 1.05% | 0.98% | |
Operating CF/Net income |
0.00 | (0.97) | 3.45 | 3.44 | |
Depreciation/Fixed assets |
0.00 | 0.28 | 0.26 | 0.25 | |
Capex/Depreciation |
— | (0.29) | (0.48) | (0.58) | |
Revenue per Share |
23.06 | 22.40 | 22.30 | 22.53 | |
Operating CF per Share |
0.00 | (6.02) | 21.34 | 21.00 | |
Capex per Share |
0.00 | (0.05) | (0.07) | (0.08) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026